Teva Launches LongActingImpact.com for Schizophrenia Care
Parsippany, New Jersey, USA & Tel Aviv, Israel, September 16, 2026 Teva Pharmaceuticals has launched LongActingImpact.com, a new educational...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Parsippany, New Jersey, USA & Tel Aviv, Israel, September 16, 2026 Teva Pharmaceuticals has launched LongActingImpact.com, a new educational...
Austin, Texas, USA, September 16, 2026 Sling Therapeutics, Inc. has announced that the first patients have been dosed in...
Pittsburgh, Pennsylvania, USA, September 15, 2026 The Braff Group has announced that its client, Community Clinical Research (CCR) of...
Research Triangle Park, North Carolina — September 3, 2026 IQVIA announced the launch of IQVIA Predictive Clinical Development, an...
MENLO PARK, Calif., August 18, 2026 BillionToOne, Inc., a molecular diagnostics company developing quantitative genetic testing technologies, has announced...
BOSTON, August 18, 2026 Curavit Clinical Research, a next-generation clinical research organization (CRO) and Remote Clinical Site, announced the...
CARY, N.C., June 30, 2026 Allucent, a global specialty Contract Research Organization (CRO) serving small and mid-sized biopharmaceutical companies,...
CONCORD, Calif., USA — April 2, 2026 Panoramic Health, through its clinical research division Panoramic Science, in collaboration with...
DUBLIN, IRELAND | January 27, 2026 — ICON plc, a global clinical research organization, announced a significant expansion of...
